Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg

Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg

Immunoglobulin (Ig) therapy is a first-line treatment for CIDP, which can be administered intravenously (IVIg) or subcutaneously (SCIg) and is often required long term. The differences between these modes of administration and how they can affect dosing strategies and treatment optimization need to...

Full description

Bibliographic Details
Main Authors: Said R. Beydoun, Khema R. Sharma, Bassam A. Bassam, Michael T. Pulley, Jeffrey Z. Shije, Ayman Kafal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Neurology
Subjects:
CIDP
IVIg
SCIg
IG therapy
dosing strategies
pharmacokinetics
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.638816/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.638816/full

Similar Items